Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
C$27.14
-1.0%
C$27.60
C$24.16
C$29.72
C$8.24BN/A695 shs500 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
-1.02%+0.85%-1.88%-6.45%+5.85%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
C$1.073.94%N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
N/A

Insider Ownership

CompanyInsider Ownership
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Purpose Canadian Financial Income Fund Series ETF stock logo
BNC
Purpose Canadian Financial Income Fund Series ETF
206,500303.60 millionN/ANot Optionable

Recent News About These Companies

(BNC) Market Dynamics and Trading Signals
(BNC) Equity Market Report
(BNC) Market Performance Analysis
Purpose Credit Opportunities Fund ETF (CROP)
MFT:CA Mackenzie Floating Rate Income ETF
American Funds Income Fund of Amer C
Purpose Investments Inc. Announces September 2024 Distributions
Calamos CEF Income & Arbitrage ETF (CCEF)
Dodge & Cox Income Fund;I

Media Sentiment Over Time

Top Headlines

View All Headlines
Purpose Canadian Financial Income Fund Series ETF stock logo

Purpose Canadian Financial Income Fund Series ETF TSE:BNC

C$27.14 -0.28 (-1.02%)
As of 03/27/2025 03:19 PM Eastern

Telesta Therapeutics Inc. is a human therapeutics company. The Company is a biotechnology company, which is focused on the licensing/acquisition and development of transformational therapeutics for the treatment of human diseases, such as cancer, immune diseases and targeted rare diseases. The Company focuses on developing drug candidate, Mycobacterium phlei cell wall-nucleic acid complex (MCNA) for the treatment of non-muscle invasive bladder cancer. The Company owns a manufacturing facility for MCNA at Montreal, Quebec. The Company has not generated any revenues.